BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38513685)

  • 1. A step forward in the journey towards hookworm vaccines.
    Keiser J; Bouchery T
    Lancet Infect Dis; 2024 Jul; 24(7):673-674. PubMed ID: 38513685
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccines for hookworm infection.
    Hotez PJ; Ghosh K; Hawdon J; Narasimhan S; Jones B; Bethony J
    Pediatr Infect Dis J; 1997 Oct; 16(10):935-40. PubMed ID: 9380467
    [No Abstract]   [Full Text] [Related]  

  • 3. The potential economic value of a hookworm vaccine.
    Lee BY; Bacon KM; Bailey R; Wiringa AE; Smith KJ
    Vaccine; 2011 Feb; 29(6):1201-10. PubMed ID: 21167860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model for product development of vaccines against neglected tropical diseases: a vaccine against human hookworm.
    Bottazzi ME; Brown AS
    Expert Rev Vaccines; 2008 Dec; 7(10):1481-92. PubMed ID: 19053205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivalent anthelminthic vaccine to prevent hookworm and schistosomiasis.
    Hotez PJ; Bethony JM; Oliveira SC; Brindley PJ; Loukas A
    Expert Rev Vaccines; 2008 Aug; 7(6):745-52. PubMed ID: 18665774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human hookworm vaccine: recent updates and prospects for success.
    Bottazzi ME
    J Helminthol; 2015 Sep; 89(5):540-4. PubMed ID: 25850789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New technologies for the control of human hookworm infection.
    Hotez PJ; Bethony J; Bottazzi ME; Brooker S; Diemert D; Loukas A
    Trends Parasitol; 2006 Jul; 22(7):327-31. PubMed ID: 16709466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunology of human hookworm infections.
    McSorley HJ; Loukas A
    Parasite Immunol; 2010 Aug; 32(8):549-59. PubMed ID: 20626810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparison of the Quality of Informed Consent for Clinical Trials of an Experimental Hookworm Vaccine Conducted in Developed and Developing Countries.
    Diemert DJ; Lobato L; Styczynski A; Zumer M; Soares A; Gazzinelli MF
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005327. PubMed ID: 28114401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty-five-year research progress in hookworm excretory/secretory products.
    Abuzeid AMI; Zhou X; Huang Y; Li G
    Parasit Vectors; 2020 Mar; 13(1):136. PubMed ID: 32171305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental approaches to the development of a recombinant hookworm vaccine.
    Hotez PJ; Ghosh K; Hawdon JM; Narasimhan S; Jones B; Shuhua X; Sen L; Bin Z; Haechou X; Hainan R; Heng W; Koski RA
    Immunol Rev; 1999 Oct; 171():163-71. PubMed ID: 10582170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of T cell responses to co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in healthy adults in Gabon.
    Mouwenda YD; Betouke Ongwe ME; Sonnet F; Stam KA; Labuda LA; De Vries S; Grobusch MP; Zinsou FJ; Honkpehedji YJ; Dejon Agobe JC; Diemert DJ; van Leeuwen R; Bottazzi ME; Hotez PJ; Kremsner PG; Bethony JM; Jochems SP; Adegnika AA; Massinga Loembe M; Yazdanbakhsh M
    PLoS Negl Trop Dis; 2021 Oct; 15(10):e0009732. PubMed ID: 34597297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of rats against nippostrongylus brasiliensis with worm antigens by oral administration.
    Poulain J; Pery P; Luffau G
    Ann Immunol (Paris); 1976; 127(2):209-13. PubMed ID: 945711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological studies with Nippostrongylus brasiliensis: a search for functional antigens in larval stages.
    Katiyar JC; Govil P; Sen AB
    Indian J Exp Biol; 1972 May; 10(3):201-4. PubMed ID: 4675557
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults.
    Diemert DJ; Freire J; Valente V; Fraga CG; Talles F; Grahek S; Campbell D; Jariwala A; Periago MV; Enk M; Gazzinelli MF; Bottazzi ME; Hamilton R; Brelsford J; Yakovleva A; Li G; Peng J; Correa-Oliveira R; Hotez P; Bethony J
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005574. PubMed ID: 28464026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled human infection models to evaluate schistosomiasis and hookworm vaccines: where are we now?
    Koopman JPR; Driciru E; Roestenberg M
    Expert Rev Vaccines; 2021 Nov; 20(11):1369-1371. PubMed ID: 34225549
    [No Abstract]   [Full Text] [Related]  

  • 17. HOOKWORM campaign.
    Annu Rep Qld Health Educ Counc Honour Minist Health Home Aff; 1946; 4():58. PubMed ID: 20245530
    [No Abstract]   [Full Text] [Related]  

  • 18. Simplified quantitative methods for hookworm control programs.
    SCOTT JA
    Am J Trop Med Hyg; 1946 May; 26():331-7. PubMed ID: 20988059
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular mechanisms of hookworm disease: stealth, virulence, and vaccines.
    Pearson MS; Tribolet L; Cantacessi C; Periago MV; Valero MA; Jariwala AR; Hotez P; Diemert D; Loukas A; Bethony J
    J Allergy Clin Immunol; 2012 Jul; 130(1):13-21. PubMed ID: 22742835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immune response to nematode infections.
    Jarrett EE; Urguhart GM
    Int Rev Trop Med; 1971; 4():53-96. PubMed ID: 4945390
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.